# NCCH2006/MK010 Trial (FORTUNE Trial)

> **NCT04962867** · PHASE2 · RECRUITING · sponsor: **National Cancer Center, Japan** · enrollment: 75 (estimated)

## Conditions studied

- Advanced or Recurrent Solid Tumors
- FGFR Gene Alterations

## Interventions

- **DRUG:** E7090

## Key facts

- **NCT ID:** NCT04962867
- **Lead sponsor:** National Cancer Center, Japan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-15
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04962867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04962867, "NCCH2006/MK010 Trial (FORTUNE Trial)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04962867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*